Amplifon
€11.56Change from previous close: −1.95%Absolute change: −€0.23
At a glance
- Revenue growth
- −0.56%
- 2025 vs 2024
- Net income growth
- −37.17%
- 2025 vs 2024
- Net margin
- 3.8%
- 2024: 6.0%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total revenue | 606 | 580 | 649 | 593 | 588 |
| Cost of revenue | 441 | 450 | -242 | 446 | 450 |
| Gross profit | 165 | 130 | 891 | 146 | 138 |
| Operating income | 89.4 | 54.3 | 48.1 | 69.0 | 58.8 |
| EBIT | 66.4 | 37.1 | 44.0 | 65.5 | 60.1 |
| EBITDA | 142 | 113 | 122 | 144 | 139 |
| Interest expense | 13.1 | 13.9 | 17.7 | 14.0 | 13.4 |
| Pre-tax income | 53.3 | 23.2 | 26.3 | 51.5 | 46.7 |
| Income tax | 14.7 | 12.6 | 9.4 | 16.3 | 13.8 |
| Net income | 38.6 | 10.5 | 16.9 | 35.2 | 32.9 |
| Net income to common shareholders | 38.6 | 10.5 | 16.9 | 35.2 | 32.9 |
| Basic EPS | 0.15 | 0.05 | 0.08 | 0.16 | 0.15 |
| Diluted EPS | 0.15 | 0.05 | 0.08 | 0.16 | 0.15 |
| Average shares (basic) | 266 | 220 | 220 | 222 | 225 |
| Average shares (diluted) | 266 | 220 | 220 | 222 | 225 |